专利检索 ap:("Celgene Corporation") AND inv:"Keming Zhu" 第 1 页

1.

发明授权
MK2 inhibitors, the synthesis thereof, and intermediates thereto 有权

公开(公告)号：US12049470B2

公开(公告)日：2024-07-30

申请号：US17587555

申请日：2022-01-28

申请人： Celgene Corporation

发明人： Alexander L. Ruchelman , John R. Coombs , Keming Zhu , Daniel Lim , Candice Lee Joe , David T. George , Bin Zheng , Dong Lin

IPC分类号： C07D215/227 , C07C255/50 , C07D215/58 , C07D495/04 , C07D495/14

CPC分类号： C07D495/14 , C07C255/50 , C07D215/58 , C07D495/04

摘要： The present disclosure provides novel synthetic intermediates useful in the synthesis of MK2 kinase inhibitors.

2.

发明申请
MK2 INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO 有权

公开(公告)号：US20220259222A1

公开(公告)日：2022-08-18

申请号：US17587555

申请日：2022-01-28

申请人： Celgene Corporation

发明人： Alexander L. Ruchelman , John R. Coombs , Keming Zhu , Daniel Lim , Candice Lee Joe , David T. George , Bin Zheng , Dong Lin

IPC分类号： C07D495/14 , C07C255/50 , C07D215/58 , C07D495/04

摘要： The present disclosure provides novel synthetic intermediates useful in the synthesis of MK2 kinase inhibitors.